306 related articles for article (PubMed ID: 2642725)
21. [Factors influencing hematopoiesis--a new therapeutic alternative?].
Austgulen R
Nord Med; 1989; 104(1):16-7. PubMed ID: 2643079
[TBL] [Abstract][Full Text] [Related]
22. [Colony stimulating factor].
Takaku F
Gan To Kagaku Ryoho; 1989 Nov; 16(11):3550-3. PubMed ID: 2817907
[TBL] [Abstract][Full Text] [Related]
23. Combinations of colony-stimulating factors promote enhanced proliferative potential in enriched granulocyte-macrophage colony-forming cells.
Heyworth CM; Dexter TM; Nicholls SE; Whetton AD
Exp Hematol; 1994 Oct; 22(11):1089-94. PubMed ID: 7925776
[TBL] [Abstract][Full Text] [Related]
24. Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) in bone marrow failure.
Antin JH; Smith BR; Holmes W; David RN; Rosenthal S
Behring Inst Mitt; 1988 Aug; (83):149-53. PubMed ID: 3071331
[TBL] [Abstract][Full Text] [Related]
25. Granulocyte-macrophage colony-stimulating factor (GM-CSF) in the management of cancer.
Fan D; O'Brian CA; Ioannides CG; Clyne RK
In Vivo; 1991; 5(6):571-7. PubMed ID: 1810441
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A
Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
[TBL] [Abstract][Full Text] [Related]
27. Human recombinant hemopoietic growth factors G-CSF and GM-CSF: first results of clinical trials.
Nissen-Druey C
Nouv Rev Fr Hematol (1978); 1989; 31(2):99-101. PubMed ID: 2475852
[No Abstract] [Full Text] [Related]
28. Potential role of granulocyte-macrophage colony stimulating factor in patients with HIV infection.
Mitsuyasu RT; Golde DW
Behring Inst Mitt; 1988 Aug; (83):139-44. PubMed ID: 3071329
[TBL] [Abstract][Full Text] [Related]
29. A review of the efficacy and tolerability of recombinant haematopoietic growth factors in bone marrow transplantation.
Barge AJ
Bone Marrow Transplant; 1993; 11 Suppl 2():1-11. PubMed ID: 8334433
[TBL] [Abstract][Full Text] [Related]
30. Effects of prolonged treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor.
Greenberg P; Negrin R; Nagler A; Vincent M; Donlon T
Int J Cell Cloning; 1990 Jan; 8 Suppl 1():293-300; discussion 300-2. PubMed ID: 1691248
[TBL] [Abstract][Full Text] [Related]
31. Colony-stimulating factors and tomorrow's pharmacy: why we must be ready.
Yee GC
Am J Hosp Pharm; 1989 Nov; 46(11 Suppl 2):S24-9. PubMed ID: 2690607
[TBL] [Abstract][Full Text] [Related]
32. Sequential interleukin 3 and granulocyte-macrophage-colony stimulating factor therapy in patients with bone marrow failure with long-term follow-up of responses.
Wu HH; Talpaz M; Champlin RE; Pilat SR; Kurzrock R
Cancer; 2003 Dec; 98(11):2410-9. PubMed ID: 14635076
[TBL] [Abstract][Full Text] [Related]
33. Serum colony stimulating factors in patients undergoing bone marrow transplantation: enhancing effect of recombinant human GM-CSF.
Geissler D; Niederwieser D; Aulitzky WE; Tilg H; Grünewald K; Huber C; Konwalinka G
Behring Inst Mitt; 1988 Aug; (83):289-300. PubMed ID: 3071343
[TBL] [Abstract][Full Text] [Related]
34. Introduction and overview of hematopoietic growth factors.
Gabrilove JL
Semin Hematol; 1989 Apr; 26(2 Suppl 2):1-4. PubMed ID: 2658099
[TBL] [Abstract][Full Text] [Related]
35. Recombinant human erythropoietin in combined treatment with granulocyte- or granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes.
Kasper C; Zahner J; Sayer HG
J Cancer Res Clin Oncol; 2002 Sep; 128(9):497-502. PubMed ID: 12242514
[TBL] [Abstract][Full Text] [Related]
36. Effects of CSFs in preleukemia.
Greenberg PL; Negrin R; Nagler A
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():121-6. PubMed ID: 1697191
[TBL] [Abstract][Full Text] [Related]
37. Clinical studies with granulocyte colony stimulating factor (G-CSF) in patients receiving cytotoxic chemotherapy.
Morstyn G; Campbell L; Dührsen U; Souza LM; Alton NK; Villeval JL; Nicola NA; Boyd AW; Kannourakis G; Cebon J
Behring Inst Mitt; 1988 Aug; (83):234-9. PubMed ID: 2467651
[TBL] [Abstract][Full Text] [Related]
38. Hematopoietic hormones: from cloning to clinic.
Perrine SP; Vichinsky E; Faller DV
Am J Pediatr Hematol Oncol; 1989; 11(3):268-75. PubMed ID: 2675659
[TBL] [Abstract][Full Text] [Related]
39. Phase I/II study with GM-CSF in patients with myelodysplastic syndromes.
Hoelzer D; Ganser A; Greher J; Völkers B; Walther F
Behring Inst Mitt; 1988 Aug; (83):134-8. PubMed ID: 3071328
[TBL] [Abstract][Full Text] [Related]
40. G-CSF is a major component of colony-stimulating activity (CSA) in the plasma of patients with multiple myeloma after treatment with high-dose melphalan (HDM).
Joffe JK; Bell JB; Denham S; Adshead F; Millar JL; Millar BC
Exp Hematol; 1995 Apr; 23(4):376-82. PubMed ID: 7534716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
